GILEAD SCIENCES News & Analysis

These stocks crushed third-quarter expectations and remain undervalued.

American Century Investments' low-turnover strategy invests in companies developing vaccines, treatments for neuro-cognitive diseases and innovations...

By 2050, almost 20 per cent of the global population will be over 65 and demand for healthcare will climb, says Michael Li of American Century...

Resurgences in outbreaks make it clear that ending the pandemic requires more than testing, contact tracing, and social distancing, says...

Three new vaccines for coronavirus look poised for emergency use authorisation in the US this autumn. What does that mean for investors?

The ingenuity of company management to put a positive spin on bad news should never be underestimated, says Brian Han.

The ingenuity of company management to put a positive spin on bad news should never be underestimated, says Brian Han.

It just got dearer to study commerce and economics, but young Americans at least are more upbeat about their financial future.

The medical device maker’s pioneering probe cleaner has excited the market, but Morningstar’s Nicolette Quinn has her reservations.

The online retailer hit a record in a week where the word ‘recession’ was uttered by an Aussie treasurer for the first time in three...